- Healthy brain aging is important due to the rising prevalence of age-related cognitive disorders like Alzheimer's disease.
- Brain aging is influenced by both modifiable and non-modifiable risk factors. Engaging in heart-healthy habits, cognitive activities, and social interaction may help promote healthy brain aging.
- When discussing brain health with older patients, physicians should evaluate risk factors and encourage lifestyle changes like exercise, a healthy diet, cognitive stimulation, and social engagement.
3. Objectives
• Describe why healthy brain aging is
important
• Summarize current knowledge about
brain aging
• Describe ways to approach aging
patients regarding brain health
13. 2011 Alzheimer’s Disease Facts and Figures
Dementia caregiver spouses had 6 times the
risk of incident dementia compared to those who
had spouses without dementia
Norton MC, J Am Geriatr Soc 2010
14.
15. Work Force Concerns
• 57 new geriatric psychiatrists certified
per year
• 54/120 (45%) training spots filled per
year
• Now: 1 geri psych doc per 23,000
patients
• 2030: 1 geri psych doc per 27,000
patients
ABPN, 2010 Annual Report
Jeste DV, Psychtri News 2012
20. Increased risk for cognitive decline
All low level of evidence
• Low plasma selenium
• Depression
• Diabetes
• Metabolic syndrome
• Current tobacco use
Williams JW, AHRQ Publication No. 10-E005 2010
21. Increased risk factors for AD
Moderate Level of Evidence Low Level of Evidence
• Conjugated equine estrogen + • Some NSAID’s
methyl progesterone • Depression
• Diabetes
• Mid-life hyperlipidemia
• Traumatic brain injuries in
• Pesticide exposure
• Never married, less social
support
• Current tobacco use
Williams JW, AHRQ Publication No. 10-E005 2010
45. Regular Cognitive
Engagement
• ANY mentally stimulating activity
- Reading
- Puzzles
- Games
- Musical instruments
• Pick what you may already be doing
• Pick what you like doing
46. Regular Scheduled Social
Engagement
• Regular: AT LEAST once weekly
• Scheduled: Combats apathy, supplies
structure
• Does not include errands or chores
47. • Disease
• Life Story
• Dimensions
(Personality)
• Motivated Behaviors
48. References
• Dotson VM, Beydoun MA, Zonderman AB. Recurrent depressive
symptoms and the incidence of dementia and mild cognitive
impairment. Neurology 2010;75:27-34.
• Emery VOB. Alzheimer disease: Are we intervening too late? Pro.
J Neural Trans 2011;118:1361-1378.
• Gu Y, Schupf N, Cosentino SA, et al. Nutrient intake and plasma
beta-amyloid. Neurology 2012;78:1832-1840.
• Jeste DV. Aging and mental health: Bad news and good news.
Psychiatr News 2012; 4:3.
• Katon W, Lyles CR, Parker MM, et al. Association of depression
with increased risk of dementia in patients with type 2 diabetes:
The Diabetes and Aging Study. Arch Gen Psychiatry 2012;69:410-
417.
49. References
• McHugh PR & Slavney PR. Perspectives of Psychiatry. The Johns
Hopkins University Press, 2nd edition, 1998.
• Miller KJ, Siddarth P, Gaines JM, et al. The memory fitness
program: Cognitive effects of a healthy aging intervention. Am J
Geriatri Psychiatry 2012;20:514-523.
• Norton MC, Smith KR, Ostbye T, et al. Greater risk of dementia
when spouse has dementia? The Cache County study. JAGS
2010; 58:895-900.
• Pimentel-Coelho PM & Rivest S. The early contribution of
cerebrovascular factors to pathogenesis of Alzheimer’s disease.
Eur J Neurosci 2012;35:1917-1937.
• Rodrigue KM, Kennedy KM, Devous MD, et al. Beta-amyloid
burden in healthy aging: Regional distribution and cognitive
consequences. Neurology 2012;78:387-395.
50. References
• Singh-Manoux A, Czernichow C, Elbaz A, et al. Obesity
phenotypes in midlife and cognition in early old age: The
Whitehall II cohort study. Neurology 2012;79:755-762.
• Solomon A, Kivipelto M, Soininen H. Prevention of Alzheimer’s
disease: Moving backward through the lifespan. J Alzheimer Dis
2012 [In Press].
• Vemuri P, Lesnick TG, Przybelski SA, et al. Effect of lifestyle
activities on AD biomarkers and cognition. Ann Neurol 2012 [In
Press]
• Vigen CLP, Mack WJ, Keefe RSE, et al. Cognitive effects of
atypical antipsychotic medications in patients with Alzheimer’s
disease: Outcomes from CATIE-AD. Am J Psychiatry
2011;168:831-839.